Novo Nordisk cuts full-year sales and profit guidance, stock plunges
This trading channel on the iShares Nasdaq Biotechnology Index ETF (O:IBB) (wow, that was a mouthful!) has a channel with parallel support and resistance that it is currently trading in. Oh, its down a whopping 4% today, but there may be a silver lining here to the long-side.
And right now it is sitting on support. Perhaps it breaks down here and creates a whole new mess of problems for long investors.
Or...
If support holds though, this could be a golden opportunity to buy with a tight stop-loss (especially for anything in the biotech industry). I'll be watching this ETF today and seeing if it can make some progress towards reclaiming $294 on an intraday basis, and if so, I may consider adding a position on this one here, and see if I can't ride this one back up to $310 in the short-term.
Check it out for yourself!
Which stock should you buy in your very next trade?
With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Unsure where to invest next? Get access to our proven portfolios and discover high-potential opportunities.
In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record.
With portfolios tailored for Dow stocks, S&P stocks, Tech stocks, and Mid Cap stocks, you can explore various wealth-building strategies.